APA (7th ed.) Citation

Figueras-Roca, M., Parrado-Carrillo, A., Nguyen, V., Casaroli-Marano, R. P., Moll-Udina, A., Gillies, M. C., . . . Zarranz-Ventura, J. (2021). Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age–related macular degeneration: Real world data from the Fight Retinal Blindness registry. Graefe's Archive of Clinical & Experimental Ophthalmology, 259(6), 1463. https://doi.org/10.1007/s00417-020-05016-9

Chicago Style (17th ed.) Citation

Figueras-Roca, Marc, Alba Parrado-Carrillo, Vuong Nguyen, Ricardo P. Casaroli-Marano, Aina Moll-Udina, Mark C. Gillies, Daniel Barthelmes, and Javier Zarranz-Ventura. "Treat-and-extend Versus Fixed Bimonthly Treatment Regimens for Treatment-naive Neovascular Age–related Macular Degeneration: Real World Data from the Fight Retinal Blindness Registry." Graefe's Archive of Clinical & Experimental Ophthalmology 259, no. 6 (2021): 1463. https://doi.org/10.1007/s00417-020-05016-9.

MLA (9th ed.) Citation

Figueras-Roca, Marc, et al. "Treat-and-extend Versus Fixed Bimonthly Treatment Regimens for Treatment-naive Neovascular Age–related Macular Degeneration: Real World Data from the Fight Retinal Blindness Registry." Graefe's Archive of Clinical & Experimental Ophthalmology, vol. 259, no. 6, 2021, p. 1463, https://doi.org/10.1007/s00417-020-05016-9.